Edity Therapeutics  logo

Edity Therapeutics

Using human immune cells to deliver therapeutic proteins

22 employees · est. 2020 · Rehovot, Israel

VS
Harpoon Therapeutics logo

Harpoon Therapeutics

SPEARHEADING IMMUNOTHERAPIES

33 employees · est. 2015 · South San Francisco, United...

Harpoon Therapeutics is the older company (2020 vs 2015).

Side-by-Side Comparison

Edity Therapeutics Harpoon Therapeutics
Founded
2020 2015 older
Headquarters
Rehovot, Israel South San Francisco, United States
Employees
22 33
Industry
Biotechnology, Health and Wellness, Medical Devices Biotechnology, Health Care, Health and Wellness
Funding Stage
Seed Post Ipo Equity
Total Funding
Not tracked yet $255.00M
Funding Rounds
3 5
Services
Not tracked yet R&D in various therapeutic areas, Clinical trials, Patient assistance programs, Business development and licensing, Merck Medical Outreach Program
Target Customers
Not tracked yet Patients, Healthcare professionals, Investors, Pharmaceutical distributors, Healthcare providers
Taxonomy
Gene Editing, Cell Therapy, Immune Cells, Therapeutic Proteins, Drug Delivery, In-vivo Gene Editing, T-cells, Cancer, Intracellular Pathways, Target Cells, Enzyme Therapy, Immunotherapy, Innovation, Startup Immunotherapy, Oncology, T Cell Engagers, Tri-specific T Cell Activating Construct (TriTAC), Solid Tumors, Hematologic Malignancies, ProTriTAC, Prodrug Concept, Extended Release TriTAC-XR, Cancer Treatment, Immune System Therapy, Clinical-stage Company, Novel Drug Development, Proprietary Technology
Website
edity-tx.com harpoontx.com
Edity Therapeutics  logo

About Edity Therapeutics

Edity Therapeutics, established in 2020, is a biotechnology startup hailing from Israel that is making waves with its pioneering approach to using human immune cells for delivering therapeutic proteins. The company's platform offers a revolutionary way to transfer these proteins to the target cells...

Harpoon Therapeutics logo

About Harpoon Therapeutics

Harpoon Therapeutics, established in 2015, is a notable player in the Biotechnology and Health Care sectors, based in the United States. The company operates under the slogan SPEARHEADING IMMUNOTHERAPIES and is primarily focused on developing innovative therapies to harness the immune system for tre...

We will tell you when either one moves

BounceWatch watches Edity Therapeutics and Harpoon Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Edity Therapeutics and Harpoon Therapeutics — by email.

Frequently Asked Questions

Edity Therapeutics — Using human immune cells to deliver therapeutic proteins. Harpoon Therapeutics — SPEARHEADING IMMUNOTHERAPIES. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Edity Therapeutics has raised undisclosed funding while Harpoon Therapeutics has raised $255.00M.
Edity Therapeutics and Harpoon Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Edity Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Edity Therapeutics on 12 Sep 2024, and Harpoon Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes